Dr. Harry Bear, MD

• General Surgery

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Virginia Commonwealth University Medical Center

  Fellowship Hospital, 1984

• Brigham And Womens Hospital

  Residency Hospital, 1981

• Brigham And Womens Hospital

  Internship Hospital, 1979

• Virginia Commonwealth University School Of Medicine

  Medical School, 1975

• Methyl Binding Domain Protein 2 (MBD2) dependent proliferation and survival of breast cancer cells, 2011-06-21

• Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies, 2020-08-24

• Phenotype, functions and fate of adoptively transferred tumor draining lymphocytes activated ex vivo in mice with an aggressive weakly immunogenic mammary carcinoma, 2010-11-04

• Germline genome-wide association studies in women receiving neoadjuvant chemotherapy with or without bevacizumab, 2018-04-30

• Activated NK T cells and NK cells render T cells resistant to MDSC and result in an effective adoptive cellular therapy against breast cancer in the FVBN202 transgenic mouse§, 2011-06-13

• Mast cells critically augment myeloid derived suppressor cell activity, 2012-06-15

• Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients, 2013-06-12

• Near-Infrared Imaging of Adoptive Immune Cell Therapy in Breast Cancer Model Using Cell Membrane Labeling, 2014-10-21

• Neighborhood disadvantage and biological aging biomarkers among breast cancer patients, 2022-06-30

• Peripheral blood mononuclear cells of patients with breast cancer can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells, 2013-10-25

• Modified breast cancer model for preclinical immunotherapy studies, 2016-06-08

• The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40, 2016-11-18

• Resection of the Primary Tumor Improves Survival in Metastatic Breast Cancer by Reduction of Overall Tumor Burden, 2013-03-13

• Expansion of melanoma-specific lymphocytes in alternate gamma chain cytokines: gene expression variances between T cells and T cell subsets exposed to IL-2 versus IL-7/15, 2014-09-19

• A signature of immune function genes associated with recurrence-free survival in breast cancer patients, 2011-04-11

• Persistent EGFR/K-RAS/SIAH pathway activation drives chemo-resistance and early tumor relapse in triple-negative breast cancer, 2022-06-22

• Tumor escape and progression of HER-2/neu negative breast cancer under immune pressure, 2011-03-31

• Tumor-reactive immune cells protect against metastatic tumor and induce immunoediting of indolent but not quiescent tumor cells, 2016-02-29

• A Phase II Study of 3'-Deoxy-3'-18F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688, 2015-09-10

• Perceived Stress Levels, Chemotherapy, Radiation Treatment and Tumor Characteristics Are Associated with a Persistent Increased Frequency of Somatic Chromosomal Instability in Women Diagnosed with Breast Cancer: A One Year Longitudinal Study, 2015-07-15

• Cost-effectiveness of palbociclib in early breast cancer patients with a high risk of relapse: Results from the PENELOPE-B trial, 2022-09-05

• Angiopoietin pathway gene expression associated with poor breast cancer survival, 2017-01-06

• IL-7 + IL-15 are superior to IL-2 for the ex vivo expansion of 4T1 mammary carcinoma-specific T cells with greater efficacy against tumors in vivo, 2009-10-14

• Medicaid Expansion and Access to Care among Cancer Survivors: A Baseline Overview, 2015-12-11

• Expansion of T Cells with Interleukin-21 for Adoptive Immunotherapy of Murine Mammary Carcinoma, 2017-01-29

• Using the 21 Gene Assay from Core Needle Biopsies to Choose Neoadjuvant Therapy for Breast Cancer: A Multicenter Trial, 2017-04-13

• Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial, 2019-12-05

• Peripheral blood mononuclear cells of breast cancer patients can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells, 2013-11-07

• Addition of Interleukin-21 for Expansion of T-Cells for Adoptive Immunotherapy of Murine Melanoma, 2015-04-20

• Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function, 2009-10-22

• DNA methyltransferase inhibition increases efficacy of adoptive cellular immunotherapy of murine breast cancer, 2016-07-14

• If we build it they will come: targeting the immune response to breast cancer, 2019-10-29

• Bevacizumab and breast cancer: what does the future hold?, 2012-09-18

• Sentinel Node Biopsy After Neoadjuvant Systemic Therapy for Breast Cancer: The Method Matters, 2019-04-24

• Human Dosimetry and Preliminary Tumor Distribution of18F-Fluoropaclitaxel in Healthy Volunteers and Newly Diagnosed Breast Cancer Patients Using PET/CT, 2011-08-17